HEMEX is a CRO providing clinical services to European biotech and medtech companies, assisting them throughout the clinical development process to ensure that products reach the market swiftly. Located in the Basel region, a major life sciences hub, and with offices in Germany, Benelux, and the United States, we are well positioned to serve small and medium enterprises (SMEs) with multinational clinical projects. The comprehensive package of services we provide includes clinical operations, quality management, regulatory guidance, grant writing services, and fundraising options. At HEMEX, we guarantee fast and clear communication, local accessibility, and transparency to meet the objectives of our clients.
13
Total Investments
9
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Pharmaceutical
Company Overview
About Hemex
Recent Investments (13)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Mar 2024 | |
| Convertible Note | •••••• | Dec 2022 | |
| Series A | •••••• | Nov 2022 | |
| Series B | •••••• | Apr 2022 | |
| Seed | •••••• | Jun 2020 | |
|
|
Seed Round | •••••• | Apr 2020 |
|
|
Series A | •••••• | Dec 2019 |
|
|
Pre Seed Round | •••••• | Jun 2019 |
|
|
Seed Round | •••••• | May 2019 |
|
|
Series A | •••••• | May 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.